Linear atrophoderma of Moulin

From WikiMD's Wellness Encyclopedia

Linear Atrophoderma of Moulin is a rare, idiopathic, acquired, linear dermatosis that was first described by Moulin et al. in 1992. It is characterized by hyperpigmented, atrophic, linear bands that follow the lines of Blaschko. The onset is usually in childhood or early adolescence. The pathogenesis of this condition is unknown.

Clinical Features[edit | edit source]

The clinical features of Linear Atrophoderma of Moulin include the following:

  • Onset: The onset is usually in childhood or early adolescence.
  • Lesions: The lesions are hyperpigmented, atrophic, linear bands that follow the lines of Blaschko.
  • Distribution: The distribution of the lesions is usually unilateral and segmental. The trunk and limbs are the most commonly affected areas.
  • Symptoms: The condition is usually asymptomatic.

Diagnosis[edit | edit source]

The diagnosis of Linear Atrophoderma of Moulin is primarily clinical, based on the characteristic appearance of the lesions and their distribution. Histopathological examination of the lesions shows a decrease in the amount of subcutaneous fat and dermal collagen, with no inflammation or changes in the overlying epidermis.

Treatment[edit | edit source]

There is no specific treatment for Linear Atrophoderma of Moulin. Management is primarily supportive, with the aim of improving the cosmetic appearance of the lesions. Options may include the use of topical corticosteroids, calcineurin inhibitors, and cosmetic camouflage.

Prognosis[edit | edit source]

The prognosis of Linear Atrophoderma of Moulin is generally good. The condition is not associated with any systemic involvement or malignancy. However, the cosmetic impact of the lesions can be significant.

See Also[edit | edit source]

References[edit | edit source]


Linear atrophoderma of Moulin Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD